Trials / Completed
CompletedNCT06559202
Inguinal and Axillary LN Size Distribution
Evaluation of Inguinal and Axillary Lymph Node Size Distribution for Safe Intralymphatic Injection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 133 (actual)
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Recently, intralymphatic allergen-specific immunotherapy (ILIT) showed promising treatment outcomes for allergic rhinoconjunctivitis. However, the normal size distribution of superficial lymph nodes (LNs) on the trunk that are potential target LNs for ILIT has not been evaluated. The objective of this study is to investigate the distribution of LN size in inguinal and axillary area.
Detailed description
In this study, the long-axis diameters of the largest LNs in the inguinal and axillary areas were retrospectively measured in subjects who underwent chest and abdominopelvic computed tomography on the same day for health screening purposes from September 2022 to November 2022.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | chest and abdominoplevic CT | chest and abdominopelvic computed tomography on the same day for health screening purposes |
Timeline
- Start date
- 2022-09-02
- Primary completion
- 2022-11-30
- Completion
- 2022-11-30
- First posted
- 2024-08-19
- Last updated
- 2024-08-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06559202. Inclusion in this directory is not an endorsement.